Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Endicott

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2004
Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studiesJulie Welburn, Jane Endicott
International Journal for Parasitology|November 19, 2002
Cyclin-dependent kinase homologues of Plasmodium falciparumChristian Doerig, Jane Endicott, Debopam Chakrabarti
Progress in Cell Cycle Research|November 5, 2003
Cyclin-dependent kinase inhibitorsPeter M Fischer, Jane Endicott, Laurent Meijer
Biochimica Et Biophysica Acta|November 8, 2005
Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymesChristian Doerig, Oliver Billker, David Pratt, et al.
Structure (London, England : 1993)|November 8, 2003
Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibitionSimon Holton, Anais Merckx, Darren Burgess, et al.
Biochimica Et Biophysica Acta|December 20, 2005
Exploiting structural principles to design cyclin-dependent kinase inhibitorsMartin Noble, Paul Barrett, Jane Endicott, et al.
The Journal of Biological Chemistry|October 6, 2012
The ubiquitin-associated (UBA) 1 domain of Schizosaccharomyces pombe Rhp23 is essential for the recognition of ubiquitin-proteasome system substrates both in vitro and in vivoBethan Medina, Konstantinos Paraskevopoulos, Jonas Boehringer, et al.
Structure (London, England : 1993)|February 16, 2008
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor designAnais Merckx, Aude Echalier, Kia Langford, et al.
Molecular Cancer Therapeutics|September 16, 2008
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitineKarima Bettayeb, Hatem Sallam, Yoan Ferandin, et al.
Journal of Medicinal Chemistry|January 10, 2003
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effectsYvette Mettey, Marie Gompel, Virginie Thomas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 4, 2004
Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studiesJulie Welburn, Jane Endicott
International Journal for Parasitology|November 19, 2002
Cyclin-dependent kinase homologues of Plasmodium falciparumChristian Doerig, Jane Endicott, Debopam Chakrabarti
Progress in Cell Cycle Research|November 5, 2003
Cyclin-dependent kinase inhibitorsPeter M Fischer, Jane Endicott, Laurent Meijer
Biochimica Et Biophysica Acta|November 8, 2005
Protein kinases as targets for antimalarial intervention: Kinomics, structure-based design, transmission-blockade, and targeting host cell enzymesChristian Doerig, Oliver Billker, David Pratt, et al.
Structure (London, England : 1993)|November 8, 2003
Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibitionSimon Holton, Anais Merckx, Darren Burgess, et al.
Biochimica Et Biophysica Acta|December 20, 2005
Exploiting structural principles to design cyclin-dependent kinase inhibitorsMartin Noble, Paul Barrett, Jane Endicott, et al.
The Journal of Biological Chemistry|October 6, 2012
The ubiquitin-associated (UBA) 1 domain of Schizosaccharomyces pombe Rhp23 is essential for the recognition of ubiquitin-proteasome system substrates both in vitro and in vivoBethan Medina, Konstantinos Paraskevopoulos, Jonas Boehringer, et al.
Structure (London, England : 1993)|February 16, 2008
Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor designAnais Merckx, Aude Echalier, Kia Langford, et al.
Molecular Cancer Therapeutics|September 16, 2008
N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitineKarima Bettayeb, Hatem Sallam, Yoan Ferandin, et al.
Journal of Medicinal Chemistry|January 10, 2003
Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effectsYvette Mettey, Marie Gompel, Virginie Thomas, et al.
Pageof 2